OBJECTIVE: Hyperglycemia is a common comorbidity for ischemic stroke and is associated with worsened neurological outcomes. Platelets are central mediators of ischemic stroke and hyperglycemia mediates platelet hyperactivity. In this study, we investigated the contribution of platelet glucose metabolism to ischemic stroke. METHODS: Mice lacking both Glut1 and Glut3 specifically in platelets (DKO) and their littermate controls (WT) were subjected to 1-hour transient middle cerebral artery occlusion under normoglycemic and streptozotocin-induced hyperglycemic conditions after which stroke outcomes, platelet activation, and platelet-neutrophil aggregate (PNA) formation were examined. RESULTS: Under normoglycemic conditions, DKO mice were protected from ischemic stroke with smaller brain infarct volumes and improved cerebral blood flow. In addition, DKO mice had reduced platelet activation, PNA, and cerebral neutrophil recruitment after stroke. Hyperglycemia significantly increased infarct size and cerebral Evans blue extravasation and worsened neurological outcomes and cerebral blood flow in both WT and DKO mice, abolishing the protective effect witnessed under normoglycemic conditions. Flow cytometric analysis after stroke demonstrated increased platelet activation and neutrophil trafficking to the brain, independent of platelet glucose metabolism. Finally, platelets from healthy DKO mice were unable to become procoagulant upon dual agonist stimulation. Conversely, hyperglycemia increased platelet mitochondrial reactive oxygen species production which potentiated procoagulant platelet formation in WT mice and restored procoagulant platelet formation in DKO mice. CONCLUSION: Hyperglycemia aggravates ischemic stroke outcome independent of platelet glucose uptake. Furthermore, we demonstrated that hyperglycemia primes procoagulant platelet formation. This underlines the therapeutic potential for strategies targeting procoagulant platelet formation for the treatment of acute ischemic stroke.
OBJECTIVE: Hyperglycemia is a common comorbidity for ischemic stroke and is associated with worsened neurological outcomes. Platelets are central mediators of ischemic stroke and hyperglycemia mediates platelet hyperactivity. In this study, we investigated the contribution of platelet glucose metabolism to ischemic stroke. METHODS: Mice lacking both Glut1 and Glut3 specifically in platelets (DKO) and their littermate controls (WT) were subjected to 1-hour transient middle cerebral artery occlusion under normoglycemic and streptozotocin-induced hyperglycemic conditions after which stroke outcomes, platelet activation, and platelet-neutrophil aggregate (PNA) formation were examined. RESULTS: Under normoglycemic conditions, DKO mice were protected from ischemic stroke with smaller brain infarct volumes and improved cerebral blood flow. In addition, DKO mice had reduced platelet activation, PNA, and cerebral neutrophil recruitment after stroke. Hyperglycemia significantly increased infarct size and cerebral Evans blue extravasation and worsened neurological outcomes and cerebral blood flow in both WT and DKO mice, abolishing the protective effect witnessed under normoglycemic conditions. Flow cytometric analysis after stroke demonstrated increased platelet activation and neutrophil trafficking to the brain, independent of platelet glucose metabolism. Finally, platelets from healthy DKO mice were unable to become procoagulant upon dual agonist stimulation. Conversely, hyperglycemia increased platelet mitochondrial reactive oxygen species production which potentiated procoagulant platelet formation in WT mice and restored procoagulant platelet formation in DKO mice. CONCLUSION: Hyperglycemia aggravates ischemic stroke outcome independent of platelet glucose uptake. Furthermore, we demonstrated that hyperglycemia primes procoagulant platelet formation. This underlines the therapeutic potential for strategies targeting procoagulant platelet formation for the treatment of acute ischemic stroke.
Authors: S Toshima; A Hasegawa; M Kurabayashi; H Itabe; T Takano; J Sugano; K Shimamura; J Kimura; I Michishita; T Suzuki; R Nagai Journal: Arterioscler Thromb Vasc Biol Date: 2000-10 Impact factor: 8.311
Authors: Frederik Denorme; Friederike Langhauser; Linda Desender; Aline Vandenbulcke; Hanspeter Rottensteiner; Barbara Plaimauer; Olivier François; Tommy Andersson; Hans Deckmyn; Friedrich Scheiflinger; Christoph Kleinschnitz; Karen Vanhoorelbeke; Simon F De Meyer Journal: Blood Date: 2016-02-29 Impact factor: 22.113
Authors: Pavel Davizon-Castillo; Brandon McMahon; Sonia Aguila; David Bark; Katrina Ashworth; Ayed Allawzi; Robert A Campbell; Emilie Montenont; Travis Nemkov; Angelo D'Alessandro; Nathan Clendenen; Lauren Shih; Natalie A Sanders; Kelly Higa; Allaura Cox; Zavelia Padilla-Romo; Giovanni Hernandez; Eric Wartchow; George D Trahan; Eva Nozik-Grayck; Kenneth Jones; Eric M Pietras; James DeGregori; Matthew T Rondina; Jorge Di Paola Journal: Blood Date: 2019-07-16 Impact factor: 22.113
Authors: Marcel P B Jansen; Diba Emal; Gwendoline J D Teske; Mark C Dessing; Sandrine Florquin; Joris J T H Roelofs Journal: Kidney Int Date: 2016-09-28 Impact factor: 10.612
Authors: Giorgio Zauli; Barbara Toffoli; Maria Grazia di Iasio; Claudio Celeghini; Bruno Fabris; Paola Secchiero Journal: Diabetes Date: 2010-02-25 Impact factor: 9.461
Authors: Ángel Chamorro; Scott Brown; Sergio Amaro; Michael D Hill; Keith W Muir; Diederik W J Dippel; Wim van Zwam; Ken Butcher; Gary A Ford; Heleen M den Hertog; Peter J Mitchell; Andrew M Demchuk; Charles B L M Majoie; Serge Bracard; Igor Sibon; Ashutosh P Jadhav; Blanca Lara-Rodriguez; Aad van der Lugt; Elizabeth Osei; Arturo Renú; Sébastien Richard; David Rodriguez-Luna; Geoffrey A Donnan; Anand Dixit; Mohammed Almekhlafi; Sandrine Deltour; Jonathan Epstein; Benoit Guillon; Serge Bakchine; Meritxell Gomis; Richard du Mesnil de Rochemont; Demetrius Lopes; Vivek Reddy; Gernot Rudel; Yvo B W E M Roos; Alain Bonafe; Hans-Christoph Diener; Olvert A Berkhemer; Geoffrey C Cloud; Stephen M Davis; Robert van Oostenbrugge; Francis Guillemin; Mayank Goyal; Bruce C V Campbell; Bijoy K Menon Journal: Stroke Date: 2019-03 Impact factor: 7.914
Authors: Frederik Denorme; Bhanu Kanth Manne; Irina Portier; Alicia S Eustes; Yasuhiro Kosaka; Benjamin T Kile; Matthew T Rondina; Robert A Campbell Journal: Blood Date: 2020-02-06 Impact factor: 25.476
Authors: Frederik Denorme; Irina Portier; John L Rustad; Mark J Cody; Claudia V de Araujo; Chieko Hoki; Matthew D Alexander; Ramesh Grandhi; Mitchell R Dyer; Matthew D Neal; Jennifer J Majersik; Christian C Yost; Robert A Campbell Journal: J Clin Invest Date: 2022-05-16 Impact factor: 19.456
Authors: Frederik Denorme; John L Rustad; Irina Portier; Jacob L Crandell; Claudia V de Araujo; Mark J Cody; Robert A Campbell; Christian C Yost Journal: Pediatr Res Date: 2022-07-28 Impact factor: 3.953